Organic Active Ingredients TRIZ Cases
- Postpartum Mood Treatment via Antioxidant and Amino Acid Regimen
A timed supplement regimen using antioxidants, tryptophan, and tyrosine reduces postpartum depression severity without antidepressant side effects.
- Selective Muscarinic Agonist Presbyopia Treatment
Selective M1/M3 agonists combined with cycloplegics improve near vision while maintaining distance acuity and reducing ciliary spasms.
- Vitamin D3 Crystallization Purity via Ethyl Acetate Hexane Solvent
Ethyl acetate and hexane solvent mixtures crystallize vitamin D3 to exclude contaminants, overcoming chromatography time consumption.
- Eleutheroside B Composition for Neuroinflammation Treatment
Eleutheroside B modulates astrocyte and microglia activation to reduce pro-inflammatory cytokines, addressing ineffective current therapies.
- Propolis Carnosic Acid Synergy Against Cryptococcus
Merging propolis with carnosic acid creates a synergistic formulation that overcomes antifungal resistance while accelerating pathogen elimination.
- 5-Amino-4-Hydroxypentoyl Amides for Drug-Resistant HIV Protease Inhibition
Novel 5-amino-4-hydroxypentoyl amides act as potent HIV protease inhibitors with reduced plasma protein binding.
- LincRNA Targeting for B-ALL Detection and Therapy
Targeting BALIR-2 lincRNA expression enables early detection and reduces toxicity compared to conventional chemotherapy.
- Agomelatine and Norepinephrine Reuptake Inhibitor Combination for Resistant Depression
Combining agomelatine with a norepinephrine reuptake inhibitor creates a synergistic pharmaceutical composition.
- Sugar Chain DCIR Ligands for Osteoclast Inhibition
Specific sugar chain structures lacking sialic acid at non-reducing terminals regulate DCIR signaling to treat bone metabolic disorders.
- Monomethyl Fumarate Administration With GSTT1 Screening
Screening for GSTT1 enzyme levels before treatment prevents lymphopenia and reduces infection risk during monomethyl fumarate therapy.
- Antibodies Targeting Misfolded SOD1 Epitopes for Neurodegenerative Disease Therapy
Selective antibodies recognize conformational changes in misfolded SOD1, resolving the trade-off between treatment safety and targeting specificity.
- Glucocorticosteroid Suspension Sterilization via Controlled Heating
Controlled heating at 50-95°C with homogenization prevents particle growth and drug degradation during glucocorticosteroid suspension sterilization.
- Modified Nucleic Acids Enhance PAH Enzyme Activity for PKU Treatment
Modified nucleic acids mimic HULC and Pair lncRNAs to increase phenylalanine hydroxylase binding affinity.
- Rho Kinase Inhibitors for Cerebral Aneurysm Treatment
Rho kinase inhibitors replace surgical resection by restoring vascular integrity, reducing cerebral cavernous malformation growth and rupture risk.
- Phenothiazine Diaminium Salts for Alzheimer's Disease
Novel phenothiazine diaminium salts improve stability and absorption for neurodegenerative disease treatment.
- Hydrophilic HASA-Gel Matrix for Localized Homeopathic Delivery
Hydrophilic HASA-gel matrix maintains homeopathic compounds in an aqueous environment, extending localized treatment duration for severe injuries.
- Punctal Plug Sustained Drug Release for Glaucoma
Porous composite punctal plugs sustain drug release to halt vision loss without frequent dosing.
- Enzalutamide Synthesis via Room Temperature Base Catalysis
Replacing hazardous acetone cyanohydrin with sodium hydroxide in THF reduces impurity formation and improves yield.
- Imidazopyridyl Compounds Selective Aldosterone Synthase Inhibition
Imidazopyridyl compounds inhibit CYP11B2 selectively, avoiding sexual side effects and hyperkalemia from nonselective receptor antagonists.
- Superabsorbent Polymer Matrix for Abuse-Deterrent Controlled Release
A controlled release formulation uses a superabsorbent polymer core to trap microparticles within a hard gel structure.
- Paliperidone Matrix Without Surfactants for Stable Prolonged Release
A paliperidone matrix uses carbomer and polyethylene oxide to provide sustained drug release over 12 to 24 hours.
- HSET Inhibitor Selective Cancer Cell Death via Centrosome Clustering
RNAi agents inhibit HSET to kill cancer cells with extra centrosomes while sparing normal cells.
- Oil-Based Solid Composition Stability via Acrylic Polymer Mediator
An acrylic acid-based water-soluble polymer prevents separation in oil-based solid compositions containing polyhydric alcohol dispersants.
- Synthetic Circular DNA Vectors Without Bacterial Signatures
Non-viral circular DNA vectors lacking bacterial origins deliver therapeutic genes for long-term episomal expression.